XML 30 R31.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Deficit (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Feb. 21, 2020
Feb. 21, 2020
Feb. 13, 2020
Jan. 02, 2020
Jun. 17, 2019
Feb. 25, 2019
Jan. 02, 2019
Jan. 02, 2017
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2016
Stock options outstanding                 5,222,863   3,835,366 3,846,299  
Stock options outstanding weighted average exercise price     $ 1.75           $ 1.45   $ 1.34 $ 1.36  
Stock options intrinsic value                 $ 1,522,414   $ 635,536    
Number of stock options granted                 1,387,497   126,567    
Stock option weighted average exercise price per share                 $ 1.75   $ 1.15    
Stock options granted, term     10 years           6 years 7 days   7 years 2 months 12 days    
Number of stock options vested                 294,698   584,895    
Warrants [Member]                          
Warrants to purchase shares 100,000 100,000                      
Warrant exercise price $ 1.25 $ 1.25                      
Class of warrant or right, outstanding                 3,826,658   3,826,658    
Class of warrant or right, outstanding, weighted average exercise price                 $ 1.05   $ 1.05    
Class of warrant or right, outstanding, intrinsic value                 $ 488,539   $ 1,375,990    
Class of warrant or right, expiration period, description The expiration date was extended by two years from January 2, 2020 to January 2, 2022.                        
Series B Preferred Stock [Member] | Placement Agent Warrants [Member]                          
Warrants to purchase shares                 127,346        
Warrant exercise price                 $ 1.25        
Series B Preferred Stock [Member] | Private Placement [Member]                          
Warrants to purchase shares                 423,291        
Warrant exercise price                         $ 1.25
Series B Preferred Stock [Member] | Private Placement [Member] | Protagenic Warrants [Member]                          
Warrants to purchase shares                 3,403,367        
Warrant exercise price                 $ 1.05        
Class of warrant or right, expiration period                 5 years        
Additional Issuance of Warrants for Debt [Member] | Series B Preferred Stock [Member] | Private Placement [Member] | Protagenic Warrants [Member]                          
Debt instrument, face amount                 $ 665,000        
Additional Issuance of Warrants for Accrued Interest [Member] | Series B Preferred Stock [Member] | Private Placement [Member] | Protagenic Warrants [Member]                          
Accrued interest                 $ 35,000        
Additional Issuance of Warrants [Member] | Series B Preferred Stock [Member] | Private Placement [Member] | Protagenic Warrants [Member]                          
Warrants to purchase shares                 295,945        
Warrant exercise price                 $ 1.25        
Employees [Member]                          
Compensation expense                 $ 298,100        
Unamortized stock option expense                 1,122,398        
Non-Employees [Member]                          
Compensation expense                 62,336        
Unamortized stock option expense                 $ 633,090        
Stock Options [Member]                          
Number of stock options granted                 1,387,497 101,567      
Stock option weighted average exercise price per share                 $ 1.00 $ 1.75      
Compensation expense                 $ 360,436 $ 451,141      
Unamortized stock option expense                 $ 1,755,488        
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition                 2 years 9 months 25 days        
Stock Options [Member]                          
Number of stock options granted         25,000 101,567              
Stock option weighted average exercise price per share         $ 1.75 $ 1.00              
Stock options granted, term         10 years 10 years              
Number of stock options vested           59,900              
Stock options fair value         $ 36,374 $ 199,807              
Number of options shares issued for settlement           59,900              
Settlement amount           $ 29,850              
Loss in settlement           $ 99,541              
Stock Options [Member] | Settlement of Accrued Compensation [Member]                          
Number of stock options granted   187,497                      
Compensation expense   $ 93,950                      
Stock Options [Member] | Vest bi-Weekly Over Two Months [Member]                          
Number of stock options vested           41,667              
Stock Options [Member] | Options Vested Immediately [Member]                          
Number of stock options vested   187,497                      
Stock Options [Member] | Options Vested Over 12 Months [Member]                          
Number of stock options vested   510,000                      
Stock Options [Member] | Options Vested Over 24 Months [Member]                          
Number of stock options vested   5,000                      
Stock Options [Member] | Options Vested Over 36 Months [Member]                          
Number of stock options vested   420,000                      
Stock Options [Member] | Options Vested Over 48 Months [Member]                          
Number of stock options vested   265,000                      
Stock Options [Member] | Sixteen Individuals [Member]                          
Number of stock options granted   1,387,497                      
Stock option weighted average exercise price per share   $ 1.75                      
Stock Options [Member] | Twelve Related Parties [Member]                          
Number of stock options granted   1,362,497                      
Stock option weighted average exercise price per share   $ 1.75                      
The 2016 Plan [Member]                          
Number of additional shares grants for issuance       567,378     564,378 564,378          
Number of shares available for grant       1,693,134     1,693,134 1,693,134 4,868,623   4,304,245    
Share-based payment award, expiration period                 10 years